Literature DB >> 9600621

Is interferon-alpha a neuromodulator?

N Dafny1.   

Abstract

Interferons were initially characterized for their ability to 'interfere' with viral replication, slow cell proliferation, and profoundly alter immunity. They are a group of hormone-like molecules synthesized and secreted by macrophages, monocytes, T lymphocytes, glia, and neurons. These cytokines have been shown to have several regulatory roles and diverse biological activities, including control of cellular and humoral immune responses, inflammation, and tumor regression. In addition, there are many reports indicating that interferon-alpha (IFN-alpha) participates in the regulation of various cellular and humoral processes such as the endocrine system modulates behavior, brain activity, temperature, glucose sensitive neurons, feeding pattern and opiate activity. Therefore, IFN-alpha can be considered as a physiological modulator, with only one of its functions being the ability to hinder viral replication intracellularly.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600621     DOI: 10.1016/s0165-0173(97)00029-5

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  12 in total

1.  Altered central nervous system gene expression caused by congenitally acquired persistent infection with lymphocytic choriomeningitis virus.

Authors:  Stefan Kunz; Jillian M Rojek; Amanda J Roberts; Dorian B McGavern; Michael B A Oldstone; Juan Carlos de la Torre
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 2.  Type I Interferons in NeuroHIV.

Authors:  Victoria E Thaney; Marcus Kaul
Journal:  Viral Immunol       Date:  2018-09-27       Impact factor: 2.257

3.  Association of chronic fatigue syndrome with human leucocyte antigen class II alleles.

Authors:  J Smith; E L Fritz; J R Kerr; A J Cleare; S Wessely; D L Mattey
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

4.  Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.

Authors:  M Makino; Y Kitano; C Komiyama; M Hirohashi; K Takasuna
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

5.  Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits.

Authors:  Elzbieta Jacek; Brian A Fallon; Abhishek Chandra; Mary K Crow; Gary P Wormser; Armin Alaedini
Journal:  J Neuroimmunol       Date:  2012-11-08       Impact factor: 3.478

6.  Chronic administration of methylphenidate produces neurophysiological and behavioral sensitization.

Authors:  Pamela B Yang; Alan C Swann; Nachum Dafny
Journal:  Brain Res       Date:  2007-02-02       Impact factor: 3.252

7.  Interferon-α induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor.

Authors:  Cari F Kessing; William R Tyor
Journal:  J Interferon Cytokine Res       Date:  2014-12-17       Impact factor: 2.607

8.  Morphine suppresses intracellular interferon-alpha expression in neuronal cells.

Authors:  Qi Wan; Xu Wang; Yan-Jian Wang; Li Song; Shi-Hong Wang; Wen-Zhe Ho
Journal:  J Neuroimmunol       Date:  2008-06-17       Impact factor: 3.478

9.  Interferon-alpha causes neuronal dysfunction in encephalitis.

Authors:  Andrew R Sas; Heather Bimonte-Nelson; C Thetford Smothers; John Woodward; William R Tyor
Journal:  J Neurosci       Date:  2009-03-25       Impact factor: 6.167

10.  NeuroAIDS, drug abuse, and inflammation: building collaborative research activities.

Authors:  Joan W Berman; Monica J Carson; Linda Chang; Brian M Cox; Howard S Fox; R Gilberto Gonzalez; Glen R Hanson; Kurt F Hauser; Wen-Zhe Ho; Jau-Shyong Hong; Eugene O Major; William F Maragos; Eliezer Masliah; Justin C McArthur; Diane B Miller; Avindra Nath; James P O'Callaghan; Yuri Persidsky; Christopher Power; Thomas J Rogers; Walter Royal
Journal:  J Neuroimmune Pharmacol       Date:  2006-11-08       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.